Skip to search formSkip to main contentSkip to account menu

Ductal Breast Carcinoma In Situ and Invasive Lobular Carcinoma

Known as: DCIS and ILC, Mixed Lobular and Ductal Carcinoma, DCIS and Infiltrating Lobular Carcinoma 
A breast carcinoma characterized by the presence of a lobular and a ductal component. The ductal component comprises less than 50 percent of the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
A core biopsy diagnosis of atypical ductal epithelial hyperplasia is upstaged on follow-up excisional biopsy (FUEB) to in situ or… 
2004
2004
Survivin is a recently discovered member of the family of proteins that inhibits apoptosis. This anti-apoptotic compound can be… 
2001
2001
Clinical management of ductal carcinoma in situ (DCIS) remains a challenge because significant proportions of patients experience… 
Highly Cited
2000
Highly Cited
2000
When found in an otherwise benign biopsy, lobular carcinoma in situ (LCIS) has been associated with an increased risk of… 
2000
2000
Human solid tumors develop multiple genetic abnormalities that accumulate progressively in individual cells during the course of… 
Highly Cited
1997
Highly Cited
1997
Hyaluronan (HA) is one of the extracellular‐matrix components involved in wound healing, tumour growth and metastasis. Due to the… 
Highly Cited
1997
Highly Cited
1997
BACKGROUND Ductal carcinoma in situ (DCIS) represents 20%-30% of breast cancers detected by clinical screening (i.e., mammography… 
1996
1996
PURPOSE Ductal carcinoma in situ (DCIS) is increasingly detected as a nonpalpable lesion on mammographic screening performed for… 
1975
1975
A nipple aspirator device was used to obtain breast secretions for cytologic examination, as well as for viral and biochemical…